Events

Join Our
Education Events

Stay up to date on the latest news, breakthroughs, and technologies in the world of Histotripsy. Find out more at one of our upcoming events.
The HistoSonics device in operation

Introduction to Histotripsy | Minneapolis, MN

On-Site Events Held Monthly

Agenda

  • Histotripsy Mechanism of Action
  • Hands-On Demonstration
  • Clinical Evidence Plan
  • Coding and Reimbursement
Learn More

American College of Surgeons (ACS)

10/20/24 - 10/22/24 | San Francisco, CA

Contact Us for a Personal Demonstration

Learn More

SUO 2024 Annual Conference

12/4/24 - 12/6/24 | Dallas, TX

Contact Us for a Personal Demonstration

Learn More

Spectrum

1/16/25 - 1/18/25 | Miami, FL

Contact Us for a Personal Demonstration

Learn More

ASCO GI

1/23/25 - 1/25/25 | San Francisco, CA

Contact Us for a Personal Demonstration

Learn More

Society of Interventional Oncology (SIO)

1/28/25 - 2/3/25 | Las Vegas, NV

Contact Us for a Personal Demonstration

Learn More

NARUS

2/27/25 - 3/1/24 | Las Vegas, NV

Contact Us for a Personal Demonstration

Learn More

SAGES

3/12/25 - 3/15/25 | Long Beach, CA

Contact Us for a Personal Demonstration

Learn More

AHPBA

3/20/25 - 3/23/25 | Miami, FL

Contact Us for a Personal Demonstration

Learn More

SSO

3/27/25 -3/29/25 | Tampa, FL

Contact Us for a Personal Demonstration

Learn More

SIR

3/29/25 - 4/2/25 | Nashville, TN

Contact Us for a Personal Demonstration

Learn More

ECIO

4/13/25 - 4/16/25 | Rotterdam, Netherlands

Contact Us for a Personal Demonstration

Learn More

AUA

4/26/25 - 4/29/25 | Las Vegas

Contact Us for a Personal Demonstration

Learn More

Our team is bringing the power of histotripsy to patients and physicians around the world.

Meet The Team

Last updated on March 21, 2025

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

The is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by persons who have completed training performed by HistoSonics Inc., and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions and a summary of clinical trial results, including reported adverse events.

Footer last updated on March 3, 2025
X New Twitter Logo
© 2019-2025 HistoSonics®. All rights reserved.
Website Powered by Brandography